Summary
This 8-K filing from Micron Technology, Inc. announces significant updates to its supply agreements with Inotera Memories, Inc. (Inotera). The core of the announcement revolves around two new supply agreements: the "2015 Supply Agreement" and the "2016 Supply Agreement." The 2015 Supply Agreement, effective immediately and expiring December 31, 2015, continues the previous arrangement where Inotera supplies all DRAM products to Micron at a price based on a discount from market rates. The more substantial development is the "2016 Supply Agreement," which takes effect January 1, 2016, and introduces a new pricing mechanism designed to share margins equally between Micron and Inotera. This formula considers manufacturing costs for both parties, Micron's operating expenses, and Micron's global revenue per wafer. This agreement has an initial two-year term, with provisions for extension, and outlines a wind-down process if extensions are not agreed upon. Investors should note the shift in pricing strategy for 2016, which aims for a more balanced cost and profit sharing, potentially impacting both companies' profitability and supply chain stability.
Key Highlights
- 1Micron Technology and its subsidiary MSA have entered into new Supply Agreements with Inotera Memories, Inc.
- 2The 2015 Supply Agreement, effective immediately and expiring Dec 31, 2015, continues the existing DRAM supply arrangement at a market-based discount.
- 3A new 2016 Supply Agreement will commence on January 1, 2016, with a distinct pricing formula.
- 4The 2016 Supply Agreement's pricing is based on an equal sharing of margins between Micron and Inotera.
- 5The margin-sharing formula in the 2016 agreement incorporates manufacturing costs, Micron's operating expenses, and Micron's revenue per wafer.
- 6The 2016 Supply Agreement has an initial two-year term, with provisions for annual extensions thereafter.
- 7Each party can terminate the agreements upon material breach, and Micron has additional termination rights related to Inotera's financial health.